Twenty-two Abstracts to be Presented, Including New Data Analyses from the ARISTOTLE Pivotal Phase 3 Study and Real-World Data Analyses
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the American Heart Association (AHA) Scientific Sessions 2015 | BMS Newsroom
No comments:
Post a Comment